24 /100
LOW RISK
Score updated Jul 14, 2026

TNDM — Tandem Diabetes Care, Inc. Dilution Risk Tracker

Track TNDM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TNDM — Get alerts when the score changes →

As of July 14, 2026, Tandem Diabetes Care, Inc. (TNDM) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. Tandem Diabetes Care, Inc. has a market capitalization of $1.18B, 68.53M shares outstanding, 277 institutional holders tracked. Key dilution vectors include approximately 204 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for TNDM.
🔔 Track TNDM — Get forecast alerts →

💹 Market Data

Market Cap$1.18B
Shares Outstanding68.53M
Float62.93M
Cash$570.26M
Debt$642.44M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 20.3% shares (2026Q1 vs prior)
277 institutional holders · 95.76M shares
#1 BlackRock, Inc. 10.69M shares
#2 UBS Group AG 7.23M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 6.08M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest12.73M
Days to Cover5.6
% of Float20.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2024
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for TNDM Shareholders

Tandem Diabetes Care, Inc. (TNDM) has a DilutionScore of 24/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for TNDM shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for TNDM in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for TNDM alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track TNDM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TNDM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for TNDM
📊 TNDM FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 TNDM Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.